Proteonomix Settles Litigation PR Newswire PARAMUS, N.J., April 1, 2013 PARAMUS, N.J., April 1, 2013 /PRNewswire/ -- Proteonomix, Inc. (OTC: PROT), a biotechnology company focused on developing...
Proteonomix Announces Extension Of Deadline /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8pt...
Proteonomix To Require Physical Exchange Of Certificates /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li {...
Proteonomix Announces Restructuring /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8pt; font-f...
Proteonomix Updates Status Of UMK-121 Testing /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8...
Proteonomix, Inc. Announces Screening of Patients with End Stage Liver Disease in its Clinical Study of UMK-121 /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; co...
Proteonomix, Inc. Announces Finalizing ECRF for Its Clinical Trial of UMK 121 in Patients with End Stage Liver Disease /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Ari...
Proteonomix, Inc. Announces Its Clinical Trial of UMK-121 in Patients with End Stage Liver Disease Has Been Listed on ClinicalTrials.gov /* Style Definitions...
Proteonomix, Inc. Announces IRB Approval for Its Clinical Trial of UMK-121 in Patients with End Stage Liver Disease PR Newswire PARAMUS, N.J., Oct. 4, 2012 PARAMUS, N.J., Oct. 4, 2012...
Proteonomix, Inc. (OTC/BB: PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today announced it has...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 4600 | 1.0E-6 | CS |
12 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 4600 | 1.0E-6 | CS |
26 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 7000 | 1.0E-6 | CS |
52 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 4375 | 1.0E-6 | CS |
156 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 32039 | 7.306E-5 | CS |
260 | -0.009499 | -99.9894736842 | 0.0095 | 0.03 | 1.0E-6 | 19231 | 0.00615576 | CS |
銘柄コード | 株価 | 出来高 |
---|---|---|
AITXArtificial Intelligence Technology Solutions Inc (PK) | US$ 0.0038 (-17.39%) | 206.33M |
GRLFGreen Leaf Innovations Inc (PK) | US$ 0.0001 (-50.00%) | 181.81M |
TKMOTekumo Inc (PK) | US$ 0.00025 (-16.67%) | 143.76M |
NSAVNet Savings Link Inc (PK) | US$ 0.00045 (-10.00%) | 141.05M |
GTCHGBT Technologies Inc (PK) | US$ 0.00015 (0.00%) | 121.84M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約